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This reply addresses a response to an article my colleagues
and I wrote on the subject of the principle of intention-
to-treat (ITT), which has become widely accepted for the
analysis of controlled clinical trials [1]. Ideally, in order to
preserve fully the immense benefit of randomization, all
randomized participants should be included in the analysis,
and all should be retained in the group to which they were
allocated. However, a strict ITT analysis is often hard to
achieve, for two main reasons: missing outcomes for some
participants and non-adherence to the trial protocol [2].
Indeed, most randomized trials have some missing
observations. A few missing outcomes do not cause a
problem, if the power of the trial is not lost by a reduced total
sample size, and if loss to follow-up is not related to a
patient’s response to treatment. There should be concern
when the frequency or the causes of dropout differ between
the intervention groups. Participants with missing outcomes
can be included in the analysis only if their outcomes are
imputed (estimated from other information that was col-
lected). Imputation of the missing data allows the analysis to
conform to ITT analysis but requires strong assumptions,
which may be hard to justify; otherwise the study should not
be undertaken. Finally, ITT corresponds to analyzing the
groups exactly as randomized, regardless of adherence to
the protocol. One of the noteworthy specific changes in the
current CONSORT 2010 Statement was to replace the
notion of ITT analysis, a widely misused term, by a more
explicit request for information about retaining participants
in their original assigned groups. Thus, in the CONSORT
checklist, the specific request for ITT analysis has been
discarded in favor of a clear description of exactly who was
included in each analysis [2].
Mohanty et al. have raised a few questions in their Letter
to the Editor about our recently published randomized
controlled trial of visualization versus neuromonitoring
of the external branch of the superior laryngeal nerve
(EBSLN) during thyroidectomy [1]. Those questions merit
a brief response. In our study, 210 consenting female
patients considered for total thyroidectomy were randomly
assigned to two groups equal in size (n = 105): visual
inspection of the EBSLN and recurrent laryngeal nerve
(RLN) versus this visual inspection plus EBSLN and RLN
neural monitoring. The primary outcome was the identifi-
cation rate of the EBSLN. The secondary outcomes
included anatomical variability of the EBSLN according to
the Cernea classification, and changes in postoperative
voice performance during a six-month follow-up. Voice
assessment included preoperative and postoperative vid-
eostrobolaryngoscopy and an analysis of maximum pho-
nation time (MPT), voice level (VL), fundamental
frequency (Fo), and voice quality rating on the GRBAS
scale [1]. Males were excluded in order to maintain a
homogeneous study group. Of note, 90 % of thyroid sur-
gery is undertaken in women, and many voice parameters
evaluated in this study, like MPT, VL, and Fo, differ sig-
nificantly between men and women. Similarly, patients
with a large goiter were not included in this study, also to
ensure the homogeneous population of the study group. As
the Cernea classification categorizes the nerve in relation to
superior thyroid vessels and the upper edge of the superior
thyroid pole, the larger the goiter the higher the incidence
of type 2B nerve, which was reported in up to 54 % of
patients with goiters above 100 ml in volume [3]. Identi-
fication of the anatomical variation of the EBSLN in our
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study was calculated for nerves at risk and not for patients.
Significant differences in distribution of all types of the
EBSLN according to the Cernea classification between
both study groups were the result of improved identifica-
tion rate of all types of the nerve variants with nerve
monitoring system. Nerve stimulation technique has a
substantial advantage in identifying all nerve types,
including Cernea type 1, which is found at a higher posi-
tion and sometimes is crowded under the laryngeal head of
the sternothyroid muscle, as well as descending types 2A
and 2B, which are most vulnerable to surgical manipulation
injury. In the study by Selvan et al. [4], a considerable
number of false-positive results were seen when visual
identification alone was used prior to electrical stimulation
of the nerve. In many cases, non-neural fibers or tendinous
fibers of the cricothyroid or inferior constrictor muscles
were wrongly assumed to be the EBSLN, but were
unmasked by the lack of an action potential when stimu-
lated. This finding suggests that visual identification of the
EBSLN without electromyographic confirmation may
likely be flawed. It is our belief that adding quantitative
data to this technique could make the process of nerve
identification and preservation more definitive and precise.
To detect a difference of 5 % in the prevalence of primary
or secondary outcomes in our trial, which is in agreement
with the study of Hurtado-Lopez et al. [5], with a two-sided
5 % significance level and a power of 90 %, a sample size of
105 patients (210 nerves at risk) per group was necessary,
given an anticipated dropout rate of 10 %. All the recruited
patients received the planned intervention and the identifi-
cation rate of the EBSLN (primary outcome) and anatomical
variability of the EBSLN according to the Cernea classifi-
cation (one of the secondary outcomes) were analyzed in all
210 patients included in the study, which is clearly reported
in the Results section and summarized in our Table 2.
However, 4 (3.8 %) patients operated on without nerve
monitoring versus 5 (4.7 %) patients operated on with nerve
monitoring were lost to follow-up (non-significant differ-
ence; 5 patients opted to withdraw from the trial, 2 patients
moved away, and 2 patients became unavailable for
unknown reasons), whereas the remaining 201 patients
completed the six-month follow-up [1]. Thus, the actual
dropout rate for evaluation of changes in postoperative voice
performance (the other secondary outcome) was far below
the anticipated dropout rate of 10 %, and the power of the
trial has not been lost by this reduction in number of the
analyzed participants. Any imputation of the missing post-
operative voice performance data was not done, as they were
impossible to be reliably estimated, and it was also not
necessary from the statistical point of view, because the
study was not in danger of being underpowered. In addition,
the outcomes of this study were analyzed in the subgroups
exactly as randomized. Taking into consideration all the
above points, I must strongly disagree with the suggestion
raised by Mohanty et al. in their letter that the analysis of
data in our trial was per protocol rather than ITT.
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